IGF1R and lung cancer: In fact, lung cancer has become an interesting model to elucidate the mechanism of action of NT157 since, in this model, signaling mediated by IGF1R-IRS1/2, STAT3, and AXL has already been reported as relevant to the development, progression, and therapeutic response of this type of cancer14,32.